Publication Topic

Massarsky A, Evans VJB, Fung ES, Yang LGL, Rogers KL, Buerger AN, Maier A, Reichard JF. A framework for assessing the safety of degraded pharmaceuticals that will be required for long-duration space missions—Part I: Framework development. Crit Rev Toxicol; doi: 10.1080/10408444.2025.2533943. Online ahead of print April 9. PMID: 4195218.

Vincent M, Wheeler M, Schaefer H, Rhoden J, Fitch S, Wikoff D. Quantitative bias assessment to facilitate assessment of (un)certainty in observational data evaluating acetaminophen use and liver cancer. Abstract 4279, Society of Toxicology 65^th Annual Meeting, San Diego, CA, March 2026.

Shobair M, Allen D, Ballone I, Brull M, Burbank M, Choksi N, Fitch S, Irizar A, et al. A machine-learning approach for the development of a knowledgebase to identify systemic toxicity mechanistic targets and evaluate biological space coverage. Abstract 5161, Society of Toxicology 65^th Annual Meeting, San Diego, CA, March 2026.

Patlewicz G, Mihalchik A, Thompson CM, East A, Borghoff S. Investigating the feasibility of deriving a new environmentally relevant Thresholds of Toxicological Concern (TTCs) from estimated human equivalent benchmark dose (eBMD_HED) values. Abstract 4013, Society of Toxicology 65^th Annual Meeting, San Diego, CA, March 2026.

Faske JB, Gong B, LeBlanc DP, Funk J, Zhou G, Kehm S, White PA, Robison T, et al. 2026. Expansion of preexisting cancer driver mutant clones is induced by the genotoxic carcinogen benzo[b]fluoranthene in MutaMouse lung. Toxicol Sci 209(3):kfag030; doi: 10.1093/toxsci/kfag030. PMID: 41859812.

Petibone DM, Shemansky JM, Robison TW, Atrakchi AH, Heflich RH. 2026. Assessing carcinogenic outcomes following short-term exposure to potentially DNA-reactive drugs: Are available data sufficient to inform risk assessment? Regul Toxicol Pharmacol 165(Feb):105993; doi: 10.1016/j.yrtph.2025.105993. PMID: 41274540.

Kennedy SB, Antonio Vital AL, Kukkola A, Miller E, Yeh A, Coffin S, Ahmed TK, Bertrand L, et al. 2026. Trends in quality and risk assessment applicability of microplastic ecotoxicity studies. J Haz Mat Adv 21(Feb):100942; doi: 10.1016/j.hazadv.2025.100942.

Coffin S, Bertrand L, Ahmed KT, de Souza Leite L, Cowger W, Sina M,… Kennedy S, et al. 2026. A probabilistic risk framework for microplastics integrating uncertainty across toxicological and environmental variability: Development and application to marine and freshwater ecosystems. J Haz Mat 503(Feb 1):141021; doi: 10.1016/j.hazmat.2025.141021. PMID: 41548305.

Jackson M, Fender CL (co-first authors), Harper S, Garcia-Jaramillo M. 2026. Metabolic disruption in salmonids following co-exposure to road runoff contaminants 6PPD-Quinone and 9,10-anthraquinone. Sci Total Environ 1011(Jan 10):181172; doi: 10.1016/j.scitotenv.2025.181172. PMID: 41389783.

Wheeler M, Wikoff D, Vincent M. Annealed Bayesian bias assessment in epidemiological studies. Session M2-H, Society for Risk Analysis (SRA) Annual Meeting, Washington, DC, December 2025.

Verwiel A, Rish W. Importance of integrating cumulative chemical exposures into cumulative impact assessment for vulnerable communities. Session T1-A, Society for Risk Analysis (SRA) Annual Meeting, Washington, DC, December 2025.

Hoffman S, Wikoff D, Brown L, Wheeler M. Advancing quantitative uncertainty assessment in next generation risk assessment. Session T2-A, Society for Risk Analysis (SRA) Annual Meeting, Washington, DC, December 2025.

Bartlett C, Rigutto G, Whittaker M (Session Chairs). Use of chemical hazard assessments to drive informed substitution in alternative assessments. Abstract 4.19. SETAC North America 46th Annual Meeting, Portland, OR, November 2025.

Heintz MM, Kennedy SB, Brown L, Fender CL, Hecker M, Hughes SA, Naile J, DeLeo P. Toxicogenomics in ecological risk assessment: Current landscape, research gaps and recommendations to increase confidence across sectors. Abstract 1.02.T-01, SETAC North America 46^th Annual Meeting, Portland, OR, November 2025.

Bare JL, Fender CL, Torres C, Panko J. Assessing environmental monitoring data quality and reliability in TSCA risk evaluations using 4-tert-octylphenol as a case study. Abstract 7.05.P-Mo-116, SETAC North America 46^th Annual Meeting, Portland, OR, November 2025.

Proctor D, Jiang X, Reichert H, Thompson C. 2025. Why rat oral cavity tumors should not be the basis of quantitative cancer risk assessment for oral exposure to hexavalent chromium. Toxicol Sci 208(1):42-47; doi: 10.1093/toxsci/kfaf112. PMID: 40795394.

Allen BC, Vincent MJ, Lipworth L, Panko JM, Suh M, Jiang X, Mumma MT, Proctor DM. 2025. Lung cancer risk assessment associated with exposure to hexavalent chromium: Results of pooled analysis of three cohorts. J Occup Environ Hyg 22(10):821-835; doi: 10.1080/15459624.2025.2502491. PMID: 40435461.

Redman AD, Key T, Koster van Groos P, Smith A, Sutherland C, Reddington T, Kung M, Davis C, et al. 2025. Integrated assessment of whole effluent toxicity tests and chemical characterization of treated Permian basin produced water. ACS ES&T Water 5(9):5275-5286; doi: 10.1021/acsestwater.5c00389.

Muller K, Unice K, Panko J, Ferrari BJD, Breider F, Wagner S. 2025. Risk assessment of tire wear in the environment—A literature review. Environ Sci Process Impacts 27(8):2212-2232; doi: 10.1039/d5em00088b. PMID: 40569214.

Rogers JM. 2025. Maternally mediated developmental toxicity. In: Comprehensive Toxicology, 4th Edition. Elsevier. In Press (Sept 2025). Available online June 9, 2025 via Reference Module in Biomedical Sciences; doi: 10.1016/B978-0-323-95488-4.00280-1.